GO:1901264 carbohydrate derivative transport: Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901264 carbohydrate derivative transport describes the directed movement of carbohydrate derivatives into, out of, or within a cell, or between cells, via transporters or pores.
• Carbohydrate derivatives include sugars, nucleosides, sialic acids, and cholesterol, all of which require specific transport mechanisms for cellular function [1,3,4,5].
• Transport is mediated by diverse protein families, including SLC and ABC transporters, which are critical for nutrient uptake, drug disposition, and metabolic homeostasis [1,6,8].
• Dysregulation of carbohydrate derivative transport is implicated in cancer, neurological disorders, and metabolic diseases, making it a therapeutic target [2,3,4].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal interrogation of transporter genes in relevant cell types [6,7].
• Studying this process requires integrated methods such as transport assays, metabolomics, and imaging to link transporter activity to cellular phenotypes [1,7].
Description
Carbohydrate derivative transport (GO:1901264) is a fundamental biological process that governs the movement of carbohydrate derivatives across cellular membranes and within cellular compartments. This process is essential for nutrient acquisition, metabolic regulation, and cellular signaling, and it relies on specialized transport proteins that facilitate the passage of sugars, nucleosides, sialic acids, and sterols [1,3,4,5]. Researchers study this term to understand how cells maintain metabolic balance and how disruptions contribute to disease [2,3,4]. The transport of carbohydrate derivatives is not limited to simple diffusion; it often requires energy and specific transporters that are tightly regulated [1,6]. For example, glucose transporters (GLUTs) and nucleoside transporters are critical for providing substrates for energy production and nucleic acid synthesis [1,3]. In cancer cells, altered transport of anthracyclines and nucleosides can affect drug sensitivity and resistance [2,3]. In bacteria, sialic acid acquisition relies on multiple transporters, highlighting the evolutionary diversity of these systems. Cholesterol trafficking, another carbohydrate derivative transport process, is vital for membrane integrity and signaling. Understanding the molecular players and regulatory mechanisms of carbohydrate derivative transport is therefore central to cell biology, pharmacology, and disease research [1,6,8].
carbohydrate derivative transport At A Glance
| GO ID | GO:1901264 |
|---|---|
| GO term | carbohydrate derivative transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of carbohydrate derivatives across membranes via transporters or pores |
| Major transporters | SLC and ABC transporter families |
| Substrates | Sugars, nucleosides, sialic acids, cholesterol, and other carbohydrate derivatives |
| Associated diseases | Cancer, neurological disorders, metabolic diseases |
| Research methods | Transport assays, CRISPR screens, metabolomics, imaging |
What Is GO:1901264?
According to the Gene Ontology, carbohydrate derivative transport (GO:1901264) is defined as the directed movement of a carbohydrate derivative into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. This definition encompasses the translocation of molecules that are chemically derived from carbohydrates, including but not limited to sugars, sugar alcohols, nucleosides, nucleotides, sialic acids, and cholesterol, across biological membranes. The process requires specific transport proteins, such as solute carriers (SLCs) and ATP-binding cassette (ABC) transporters, which facilitate the movement of these hydrophilic or amphipathic molecules through hydrophobic membrane barriers [1,6].
Why Is carbohydrate derivative transport Important in Cell Biology?
Carbohydrate derivative transport is essential for cellular metabolism, nutrient uptake, and drug disposition, and its dysfunction is linked to a wide range of human diseases, including cancer, neurological disorders, and metabolic syndromes [1,2,3,4]. Understanding the specific transporters and their regulation provides insights into basic cell biology and offers potential therapeutic targets [6,8].
• Enables uptake of essential nutrients such as glucose and nucleosides for energy and nucleic acid synthesis [1,3].
• Regulates intracellular levels of signaling molecules and metabolites [1,4].
• Influences drug pharmacokinetics and efficacy, as seen with fexofenadine enantiomers.
• Plays a role in cancer drug resistance by modulating anthracycline accumulation.
• Critical for cholesterol homeostasis and membrane function.
• Bacterial sialic acid transport is important for host-pathogen interactions.
• Dysregulation contributes to metabolic disorders and neurodegeneration [3,4].
• Provides targets for therapeutic intervention in cancer and infectious diseases [2,5].
• Essential for crop seed loading and plant development.
• Involved in blood-cerebrospinal fluid barrier function via choroid plexus transporters.
What Happens During carbohydrate derivative transport?
Substrate Recognition and Binding
In simple terms: The transporter first recognizes and binds its specific cargo, such as a sugar or nucleoside.
Transport begins with the specific binding of a carbohydrate derivative to a transporter protein. This recognition is highly selective, ensuring that only particular molecules are transported. For example, nucleoside transporters discriminate between different nucleosides and their analogs. Sugar transporters, such as GLUTs, bind glucose and related hexoses with high affinity. Sialic acid transporters in bacteria recognize specific sialic acid derivatives. The binding site is typically located within the transmembrane domains of the transporter, and conformational changes upon binding initiate the translocation process [1,6].
Translocation Across the Membrane
In simple terms: The transporter changes shape to move the cargo across the cell membrane.
After binding, the transporter undergoes conformational changes that allow the substrate to pass through the membrane. This can occur via facilitated diffusion, as with GLUTs, or via active transport, as with ABC transporters that use ATP hydrolysis [1,6]. For example, the ABC transporter ABCG2 transports anthracyclines out of cancer cells, contributing to drug resistance. In the choroid plexus, SLC and ABC transporters mediate the movement of various solutes across the blood-cerebrospinal fluid barrier. The direction of transport can be into the cell (influx), out of the cell (efflux), or between cellular compartments.
Release and Intracellular Distribution
In simple terms: Once inside, the cargo is released and can be used or stored by the cell.
Upon reaching the target compartment, the substrate is released from the transporter. For example, glucose released into the cytoplasm is immediately phosphorylated by hexokinase to prevent efflux and enter glycolysis. Nucleosides released inside the cell are salvaged into nucleotides or catabolized. Cholesterol, after transport, is distributed to the plasma membrane or endoplasmic reticulum for esterification. In bacteria, sialic acid is released into the cytoplasm and used as a carbon source or for cell surface modification. Proper release and distribution are crucial for metabolic homeostasis.
Regulation and Coupling to Cellular Signals
In simple terms: The transport process is controlled by cellular signals to match supply with demand.
Transport activity is regulated at multiple levels, including transporter expression, localization, and post-translational modifications. For instance, insulin signaling promotes translocation of GLUT4 to the plasma membrane in adipocytes and muscle cells. In cancer cells, hypoxia and oncogenic signaling can upregulate nucleoside transporters to support rapid proliferation. The pharmacokinetics of fexofenadine enantiomers are influenced by transporter-mediated uptake and efflux, highlighting the clinical relevance of transport regulation. In plants, sugar loading into seeds is regulated by phloem and plasmodesmal transport.
Key Genes Involved in GO:1901264 carbohydrate derivative transport
The following genes encode transporters and related proteins that mediate carbohydrate derivative transport across membranes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC2A1 (GLUT1) | Facilitates glucose transport across membranes | Target in cancer metabolism and blood-brain barrier studies |
| SLC2A4 (GLUT4) | Insulin-responsive glucose transporter | Diabetes and insulin resistance research |
| SLC29A1 (ENT1) | Equilibrative nucleoside transporter | Nucleoside analog drug uptake and resistance |
| SLC28A1 (CNT1) | Concentrative nucleoside transporter | Nucleoside salvage and chemotherapy |
| ABCG2 (BCRP) | Efflux transporter for anthracyclines and other drugs | Multidrug resistance in cancer |
| ABCB1 (P-gp) | Efflux pump for xenobiotics and drugs | Drug disposition and resistance |
| NPC1 | Cholesterol trafficking from lysosomes | Niemann-Pick disease and cholesterol homeostasis |
| NPC2 | Cholesterol transfer in lysosomes | Niemann-Pick disease |
| SLC35A1 | Sialic acid transporter in Golgi | Glycosylation and bacterial sialic acid acquisition |
| SLC35A2 | UDP-galactose transporter | Congenital disorders of glycosylation |
| SLC22A1 (OCT1) | Organic cation transporter | Drug pharmacokinetics and fexofenadine transport |
| SLC22A2 (OCT2) | Organic cation transporter | Renal drug secretion |
| SLC15A1 (PEPT1) | Peptide transporter | Nutrient uptake and drug absorption |
| SLC7A5 (LAT1) | Amino acid transporter | mTOR signaling and cancer growth |
| SLC16A1 (MCT1) | Monocarboxylate transporter | Lactate transport in cancer and metabolism |
| SLC5A1 (SGLT1) | Sodium-glucose cotransporter | Intestinal glucose absorption |
| SLC5A2 (SGLT2) | Sodium-glucose cotransporter | Renal glucose reabsorption and diabetes |
How Is carbohydrate derivative transport Regulated?
Carbohydrate derivative transport is regulated at transcriptional, post-transcriptional, and post-translational levels. For example, insulin signaling induces GLUT4 translocation to the plasma membrane, enhancing glucose uptake. In cancer cells, oncogenic pathways such as PI3K/AKT/mTOR upregulate nucleoside and glucose transporters to meet increased metabolic demands [1,3]. The expression of ABC transporters can be induced by chemotherapy, leading to drug resistance. In the choroid plexus, transporter expression is regulated to maintain blood-cerebrospinal fluid barrier function. Additionally, fexofenadine enantiomers exhibit stereoselective transport, influenced by transporter polymorphisms.
carbohydrate derivative transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC2A1 | GLUT1 deficiency syndrome | Knockout or point mutation in neuronal cells |
| ABCG2 | Multidrug resistance in cancer | Overexpression in cancer cell lines |
| NPC1 | Niemann-Pick type C disease | Knockout in fibroblasts or hepatocytes |
| SLC35A1 | Congenital disorder of glycosylation | Knockout in HeLa or HEK293 cells |
| SLC22A1 | Altered drug pharmacokinetics | Knockout in hepatocytes or renal cells |
Cancer and Drug Resistance
Altered carbohydrate derivative transport is a hallmark of cancer. Upregulation of glucose transporters (e.g., GLUT1) supports the Warburg effect, providing energy and biosynthetic precursors for rapid proliferation. Nucleoside transporters are critical for the uptake of cytotoxic nucleoside analogs, and their downregulation can lead to chemoresistance. Efflux transporters such as ABCG2 and ABCB1 actively pump anthracyclines and other chemotherapeutics out of cancer cells, reducing drug efficacy. Targeting these transporters is a promising strategy to overcome multidrug resistance.
Neurological Disorders and Blood-Brain Barrier
The blood-cerebrospinal fluid barrier, formed by choroid plexus epithelial cells, expresses a variety of SLC and ABC transporters that regulate the exchange of carbohydrate derivatives between blood and cerebrospinal fluid. Dysfunction of these transporters can contribute to neurological disorders by disrupting nutrient supply or allowing accumulation of toxic metabolites. For example, GLUT1 deficiency syndrome is caused by mutations in SLC2A1, leading to impaired glucose transport across the blood-brain barrier and neurological symptoms.
Metabolic and Lysosomal Storage Diseases
Cholesterol trafficking defects, such as those caused by mutations in NPC1 or NPC2, result in Niemann-Pick type C disease, characterized by lysosomal accumulation of unesterified cholesterol and progressive neurodegeneration. Similarly, defects in sialic acid transport can lead to glycosylation disorders and immune dysfunction. These examples highlight the importance of carbohydrate derivative transport in maintaining cellular and systemic homeostasis [4,5].
From carbohydrate derivative transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC2A1 affect glucose uptake and metabolism? | CRISPR knockout in cancer cell lines |
| Can point mutations in ABCG2 alter substrate specificity? | CRISPR point mutation in HEK293 cells |
| Does overexpression of ENT1 increase nucleoside analog sensitivity? | CRISPR knock-in of tagged ENT1 in cancer cells |
| How does NPC1 deficiency affect cholesterol trafficking? | Knockout in patient-derived fibroblasts |
| What is the role of SLC35A1 in sialic acid transport? | Knockout in epithelial cells |
| Can CRISPR activation of GLUT4 enhance insulin sensitivity? | Overexpression via CRISPRa in adipocytes |
How to Study the carbohydrate derivative transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport rate of specific substrates | Nucleoside and glucose transport [1,3] |
| CRISPR knockout screen | Genes affecting transport or drug sensitivity | Identifying novel transporters |
| Metabolomics | Intracellular metabolite levels | Cholesterol and sugar metabolism [1,4] |
| Live-cell imaging | Transporter localization and dynamics | GLUT4 translocation |
| Transport inhibitor profiling | Contribution of specific transporters | Anthracycline efflux |
| qPCR/Western blot | Transporter expression levels | Regulation studies |
| Patch clamp | Ion-coupled transport activity | SGLT function |
| Proteomics | Transporter protein abundance | Membrane protein profiling |
Transport Assays
Radiolabeled or fluorescent substrates are used to measure the rate of carbohydrate derivative transport across cell membranes. For example, uptake of 3H-labeled nucleosides or 14C-glucose can be quantified in cells expressing specific transporters [1,3]. Inhibitor studies, such as those using anthracycline transport inhibitors, help identify the contribution of specific transporters.
CRISPR Screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate carbohydrate derivative transport. For instance, a screen for resistance to a nucleoside analog may reveal transporters required for drug uptake. Such screens are powerful for discovering novel transport regulators.
Metabolomics and Flux Analysis
Mass spectrometry-based metabolomics measures intracellular levels of carbohydrate derivatives and their metabolites, providing insights into transport activity and metabolic flux [1,4]. Isotope tracing can further delineate transport and metabolic pathways.
Imaging and Localization
Fluorescently tagged transporters or substrates enable live-cell imaging of transport dynamics and subcellular localization. For example, GFP-tagged GLUT4 translocation can be visualized in response to insulin. Cholesterol trafficking can be monitored using filipin staining.
How CRISPR Can Be Used to Study GO:1901264 carbohydrate derivative transport
Knockout
CRISPR knockout of transporter genes (e.g., SLC2A1, ABCG2) allows researchers to assess their contribution to substrate uptake or efflux. For example, knocking out ABCG2 in cancer cells increases intracellular anthracycline accumulation, confirming its role in drug resistance. Knockout of NPC1 in fibroblasts recapitulates cholesterol trafficking defects.
Point Mutation
Introducing specific point mutations in transporter genes can mimic clinical variants or alter substrate specificity. For instance, point mutations in SLC2A1 identified in GLUT1 deficiency syndrome can be modeled to study transport kinetics. Similarly, mutations in ABCG2 can affect its efflux capacity.
Knock-in
Knock-in of tagged transporters (e.g., GFP or HA) enables visualization and purification. For example, knock-in of tagged GLUT4 allows tracking of its translocation in response to insulin. Knock-in of disease-associated mutations in NPC1 provides isogenic models for drug testing.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase transporter levels to study gain-of-function effects. Overexpression of ENT1 enhances nucleoside analog uptake and sensitivity. Overexpression of ABCG2 in cancer cells confers multidrug resistance.
How EDITGENE Supports carbohydrate derivative transport Research
Researchers studying carbohydrate derivative transport-related genes often need to determine whether a candidate gene is causally involved in substrate movement, metabolic regulation, or disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of transporters and their regulators.
Contact EDITGENE today to design your custom CRISPR model for carbohydrate derivative transport research.
Frequently Asked Questions About carbohydrate derivative transport
What is carbohydrate derivative transport GO:1901264?
It is the biological process of moving carbohydrate derivatives, such as sugars, nucleosides, and cholesterol, across cellular membranes via transporters or pores.
What genes are involved in carbohydrate derivative transport?
Key genes include SLC2A1 (GLUT1), SLC29A1 (ENT1), ABCG2, NPC1, and many other SLC and ABC transporters [1,2,3,4].
How is carbohydrate derivative transport regulated?
It is regulated by transcriptional, post-translational, and signaling mechanisms, such as insulin-induced GLUT4 translocation and oncogenic upregulation of transporters [1,3].
What diseases are associated with defects in carbohydrate derivative transport?
Diseases include cancer drug resistance, GLUT1 deficiency syndrome, Niemann-Pick type C disease, and congenital disorders of glycosylation [1,2,4,5].
What methods are used to study carbohydrate derivative transport?
Common methods include radiolabeled uptake assays, CRISPR screens, metabolomics, and live-cell imaging [1,3,4].
Can CRISPR be used to study carbohydrate derivative transport?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional studies of transporter genes [2,4].
What is the role of SLC transporters in carbohydrate derivative transport?
SLC transporters mediate the facilitated diffusion or secondary active transport of sugars, nucleosides, and other derivatives across membranes [1,3].
How does ABCG2 contribute to drug resistance?
ABCG2 is an efflux pump that transports anthracyclines and other drugs out of cancer cells, reducing their efficacy.
What is the link between cholesterol transport and Niemann-Pick disease?
Mutations in NPC1 or NPC2 cause defective cholesterol trafficking, leading to lysosomal accumulation and neurodegeneration.
Why is sialic acid transport important in bacteria?
Bacteria use multiple transporters to acquire sialic acid, which can be used as a carbon source or for surface modification, influencing host interactions.
Conclusion
Carbohydrate derivative transport (GO:1901264) is a vital biological process that underpins nutrient uptake, metabolic regulation, and drug disposition. Its dysregulation is implicated in cancer, neurological disorders, and metabolic diseases, making it a rich area for therapeutic targeting [1,2,3,4]. Advances in CRISPR-based models and analytical methods are accelerating our understanding of the specific transporters and regulatory networks involved [6,7]. EDITGENE's suite of CRISPR services empowers researchers to dissect these mechanisms with precision and speed.
References
- 1. Chen LQ et al.. 2015. Transport of sugars.. Annu Rev Biochem 84:865-94 PMID: 25747398
- 2. Mbuna J et al.. 2011. Micellar electrokinetic chromatographic analysis for in vitro accumulation of anthracyclines enhanced by inhibitors of cell membrane transporter-proteins in cancer cells.. Biomed Chromatogr 25(10):1168-74 PMID: 21241026
- 3. Belt JA et al.. 1993. Nucleoside transport in normal and neoplastic cells.. Adv Enzyme Regul 33:235-52 PMID: 8356910
- 4. Iaea DB et al.. 2015. Cholesterol trafficking and distribution.. Essays Biochem 57:43-55 PMID: 25658343
- 5. Thomas GH. 2016. Sialic acid acquisition in bacteria-one substrate, many transporters.. Biochem Soc Trans 44(3):760-5 PMID: 27284039
- 6. Kurosawa T et al.. 2026. Expression and Functional Evaluation of ABC and SLC Transporters in Human Choroid Plexus Papilloma (HIBCPP) Cells: A Human Blood-Cerebrospinal Fluid Barrier Model.. Pharm Res 43(1):137-147 PMID: 41372689
- 7. Pegler JL et al.. 2023. Sugar loading of crop seeds - a partnership of phloem, plasmodesmal and membrane transport.. New Phytol 239(5):1584-1602 PMID: 37306002
- 8. Akamine Y et al.. 2018. An update on the clinical pharmacokinetics of fexofenadine enantiomers.. Expert Opin Drug Metab Toxicol 14(4):429-434 PMID: 29635947
